{"id":69411,"date":"2022-06-13T18:30:00","date_gmt":"2022-06-13T11:30:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2022061318300069411"},"modified":"2022-06-14T21:41:49","modified_gmt":"2022-06-14T13:41:49","slug":"%e7%99%be%e6%b5%8e%e7%a5%9e%e5%b7%9e%e5%ae%a3%e5%b8%83%e7%99%be%e6%82%a6%e6%b3%bd%ef%bc%88%e6%b3%bd%e5%b8%83%e6%9b%bf%e5%b0%bc%ef%bc%89%e5%9c%a8%e5%85%a8%e7%90%8350%e4%b8%aa%e5%b8%82%e5%9c%ba","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2022061318300069411","title":{"rendered":"\u767e\u6d4e\u795e\u5dde\u5ba3\u5e03\u767e\u60a6\u6cfd\u00ae\uff08\u6cfd\u5e03\u66ff\u5c3c\uff09\u5728\u5168\u740350\u4e2a\u5e02\u573a\u83b7\u6279"},"content":{"rendered":"<p><p><i>\u7ee7\u767e\u60a6\u6cfd<\/i><i><sup>&reg;<\/sup><\/i><i>\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u540e\uff0c\u767e\u6d4e\u795e\u5dde\u6b63\u4e0e<\/i><i>NewBridge Pharmaceuticals<\/i><i>\u643a\u624b\u63a8\u52a8\u767e\u60a6\u6cfd<\/i><i><sup>&reg;<\/sup><\/i><i>\u60e0\u53ca\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08<\/i><i>MENA<\/i><i>\uff09\u7684\u60a3\u8005<\/i><\/p>\n<p><i>\u6b64\u524d\uff0c\u767e\u60a6\u6cfd<\/i><i><sup>&reg;<\/sup><\/i><i>\u5df2\u5728\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u3001\u82f1\u56fd\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u3001\u97e9\u56fd\u548c\u745e\u58eb\u7b49\u5e02\u573a\u83b7\u5f97\u6279\u51c6<\/i><\/p>\n<p><span class=\"legendSpanClass\">\u4e2d\u56fd\u5317\u4eac\u3001\u7f8e\u56fd\u9ebb\u7701\u5251\u6865\u548c\u745e\u58eb\u5df4\u585e\u5c14<\/span><span class=\"legendSpanClass\">2022\u5e746\u670813\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212; \u767e\u6d4e\u795e\u5dde\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aBGNE\uff1b\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a06160\uff1b\u4e0a\u4ea4\u6240\u4ee3\u7801\uff1a688235\uff09\u662f\u4e00\u5bb6\u7acb\u8db3\u4e8e\u79d1\u5b66\u7684\u5168\u7403\u6027\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u521b\u65b0\u3001\u53ef\u8d1f\u62c5\u7684\u836f\u7269\uff0c\u65e8\u5728\u4e3a\u5168\u7403\u60a3\u8005\u6539\u5584\u6cbb\u7597\u6548\u679c\uff0c\u63d0\u9ad8\u836f\u7269\u53ef\u53ca\u6027\u3002\u516c\u53f8\u4e8e\u4eca\u65e5\u5ba3\u5e03\uff0c\u79d1\u5a01\u7279\u536b\u751f\u90e8\u3001\u5df4\u6797\u56fd\u5bb6\u536b\u751f\u76d1\u7763\u7ba1\u7406\u5c40\u548c\u5361\u5854\u5c14\u516c\u5171\u536b\u751f\u90e8\u5df2\u6279\u51c6\u767e\u6d4e\u795e\u5dde\u7684BTK\u6291\u5236\u5242\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\uff08\u6cfd\u5e03\u66ff\u5c3c\uff09\u7528\u4e8e\u6cbb\u7597\u65e2\u5f80\u63a5\u53d7\u8fc7\u81f3\u5c11\u4e00\u79cd\u6cbb\u7597\u7684\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MCL\uff09\u6210\u4eba\u60a3\u8005\u3002\u767e\u6d4e\u795e\u5dde\u6b63\u5728\u4e0eNewBridge Pharmaceuticals\u5408\u4f5c\uff0c\u8be5\u516c\u53f8\u662f\u4e00\u5bb6\u4f4d\u4e8e\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08MENA\uff09\u7684\u4e13\u4e1a\u533b\u836f\u516c\u53f8\uff0c\u901a\u8fc7\u4e0e\u5168\u7403\u6027\u5236\u836f\u548c\u751f\u7269\u79d1\u6280\u516c\u53f8\u5408\u4f5c\uff0c\u81f4\u529b\u4e8e\u63d0\u4f9b\u836f\u54c1\u51c6\u5165\u7684\u7ebd\u5e26\u3002\u5728\u83b7\u5f97\u5f53\u5730\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u540e\uff0c\u53cc\u65b9\u5c06\u628a\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5e26\u7ed9\u79d1\u5a01\u7279\u3001\u5df4\u6797\u3001\u5361\u5854\u5c14\u3001\u6c99\u7279\u963f\u62c9\u4f2f\u3001\u963f\u62c9\u4f2f\u8054\u5408\u914b\u957f\u56fd\u53ca\u5176\u4ed6\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08MENA\uff09\u5e02\u573a\u7684\u60a3\u8005\u3002<\/p>\n<p>\u79d1\u5a01\u7279\u764c\u75c7\u63a7\u5236\u4e2d\u5fc3\u8840\u6db2\u79d1\u8d1f\u8d23\u4ebaAbdul Aziz Hamadah\u535a\u58eb\u8868\u793a\uff1a&quot;\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u662f\u6700\u5e38\u89c1\u7684\u4e94\u5927\u764c\u75c7\u7c7b\u578b\u4e4b\u4e00\uff0c\u5176\u4e2dMCL\u60a3\u8005\u7684\u9884\u540e\u5c24\u5176\u4e0d\u7406\u60f3\u3002\u8fd9\u7c7b\u60a3\u8005\u901a\u5e38\u9700\u8981\u591a\u7ebf\u6cbb\u7597\uff0c\u800c\u4e14\u540e\u7eed\u6cbb\u7597\u7684\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\u4f1a\u4e0d\u65ad\u7f29\u77ed\u3002\u6b64\u6b21\u83b7\u6279\u7684\u65b0\u4e00\u4ee3BTK\u6291\u5236\u5242\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u548c\u9ad8\u751f\u7269\u5229\u7528\u5ea6\u7684\u4e0d\u53ef\u9006\u6027BTK\u6291\u5236\u5242\uff0c\u5177\u6709\u6f5c\u5728\u66f4\u4f18\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u548c\u836f\u6548\u5b66\u7279\u6027\u3002&quot;<\/p>\n<p>\u767e\u6d4e\u795e\u5ddeMENA\u65b0\u5174\u5e02\u573a\u9ad8\u7ea7\u603b\u76d1Mohammed Al-Kapany\u8868\u793a\uff1a&quot;\u767e\u6d4e\u795e\u5dde\u7684\u613f\u666f\u662f\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u66f4\u591a\u60a3\u8005\u63d0\u4f9b\u6709\u6548\u3001\u53ef\u53ca\u4e14\u53ef\u8d1f\u62c5\u7684\u521b\u65b0\u836f\u7269\u3002\u5728\u8fc7\u53bb\u7684\u4e00\u5e74\u4e2d\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5df2\u5728MENA\u5730\u533a\u7684\u4e94\u4e2a\u56fd\u5bb6\u83b7\u6279\uff0c\u5305\u62ec\u6c99\u7279\u963f\u62c9\u4f2f\u3001\u963f\u62c9\u4f2f\u8054\u5408\u914b\u957f\u56fd\u3001\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u3002\u6b64\u6b21\u80fd\u591f\u4e3a\u66f4\u591a\u60a3\u8005\u5e26\u6765\u8fd9\u4e00\u91cd\u8981\u7684\u65b0\u6cbb\u7597\u9009\u62e9\uff0c\u6211\u4eec\u500d\u611f\u81ea\u8c6a\u3002&quot;<\/p>\n<p>NewBridge Pharmaceuticals\u603b\u88c1\u517c\u9996\u5e2d\u6267\u884c\u5b98Joe Henein\u8865\u5145\u9053\uff1a&quot;\u6211\u4eec\u5c06\u7ee7\u7eed\u4e0e\u767e\u6d4e\u795e\u5dde\u5728MENA\u5730\u533a\u8fdb\u884c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\uff0c\u4e5f\u671f\u5f85\u5c06\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5e26\u7ed9\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u7684\u533b\u751f\u53ca\u5176\u60a3\u8005\u3002&quot;<\/p>\n<p>\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u7684\u63a8\u8350\u5242\u91cf\u4e3a160 mg\u6bcf\u65e5\u4e24\u6b21\uff0c\u6216320 mg\u6bcf\u65e5\u4e00\u6b21\uff0c\u7a7a\u8179\u6216\u9910\u540e\u53e3\u670d\u5747\u53ef\u3002\u53ef\u6839\u636e\u4e0d\u826f\u53cd\u5e94\u8c03\u6574\u5242\u91cf\uff0c\u5bf9\u4e8e\u5b58\u5728\u91cd\u5ea6\u809d\u635f\u5bb3\uff0c\u6216\u6b63\u5728\u670d\u7528\u4e0e\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5b58\u5728\u6f5c\u5728\u836f\u7269\u76f8\u4e92\u4f5c\u7528\u7684\u836f\u7269\u7684\u60a3\u8005\uff0c\u53ef\u964d\u4f4e\u5242\u91cf\u3002<\/p>\n<p><b>\u5173\u4e8e\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08<\/b><b>MCL<\/b><b>\uff09<\/b>&nbsp;<\/p>\n<p>\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08NHL\uff09\u662f\u79d1\u5a01\u7279\u7b2c\u4e94\u5927\u5e38\u89c1\u7684\u764c\u75c7\u79cd\u7c7b\u4e4b\u4e00\u3002<sup>i <\/sup>MCL\u662f\u4e00\u79cd\u7f55\u89c1\u7684NHL\uff0c\u5360\u6240\u6709NHL\u75c5\u4f8b\u76845%\u3002MCL\u4e3b\u8981\u51fa\u73b0\u5728\u88ab\u79f0\u4e3a\u5957\u533a\u7684\u6dcb\u5df4\u7ed3\u5916\u7f18\u3002\u76f8\u8f83\u5973\u6027\uff0cMCL\u66f4\u591a\u53d1\u4e8e\u7537\u6027\u60a3\u8005\uff0c\u60a3\u8005\u901a\u5e38\u572860\u5c81\u5de6\u53f3\u786e\u8bca\u3002MCL\u60a3\u8005\u9884\u540e\u901a\u5e38\u8f83\u4e0d\u7406\u60f3\uff0c\u4e2d\u4f4d\u751f\u5b58\u671f\u4ec5\u4e3a3&nbsp;~&nbsp;4\u5e74\uff0c\u8bb8\u591a\u60a3\u8005\u5728\u786e\u8bca\u65f6\u5e38\u5e38\u5df2\u7ecf\u5904\u4e8e\u75be\u75c5\u665a\u671f\u3002<sup>ii<\/sup>&nbsp;<\/p>\n<p><b>\u5173\u4e8e\u767e\u60a6\u6cfd<\/b><b><sup>&reg;<\/sup><\/b><\/p>\n<p>\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\uff08\u6cfd\u5e03\u66ff\u5c3c\uff09\u662f\u4e00\u6b3e\u7531\u767e\u6d4e\u795e\u5dde\u79d1\u5b66\u5bb6\u81ea\u4e3b\u7814\u53d1\u7684\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u5c0f\u5206\u5b50\u6291\u5236\u5242\uff0c\u76ee\u524d\u6b63\u5728\u5168\u7403\u8fdb\u884c\u5e7f\u6cdb\u7684\u4e34\u5e8a\u8bd5\u9a8c\u9879\u76ee\uff0c\u4f5c\u4e3a\u5355\u836f\u548c\u4e0e\u5176\u4ed6\u7597\u6cd5\u8fdb\u884c\u8054\u5408\u7528\u836f\u6cbb\u7597\u591a\u79cdB\u7ec6\u80de\u6076\u6027\u80bf\u7624\u3002\u7531\u4e8e\u65b0\u7684BTK\u4f1a\u5728\u4eba\u4f53\u5185\u4e0d\u65ad\u5408\u6210\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u7684\u8bbe\u8ba1\u901a\u8fc7\u4f18\u5316\u751f\u7269\u5229\u7528\u5ea6\u3001\u534a\u8870\u671f\u548c\u9009\u62e9\u6027\uff0c\u5b9e\u73b0\u5bf9BTK\u86cb\u767d\u5b8c\u5168\u3001\u6301\u7eed\u7684\u6291\u5236\u3002\u51ed\u501f\u4e0e\u5176\u4ed6\u83b7\u6279BTK\u6291\u5236\u5242\u5b58\u5728\u5dee\u5f02\u5316\u7684\u836f\u4ee3\u52a8\u529b\u5b66\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u80fd\u5728\u591a\u4e2a\u75be\u75c5\u76f8\u5173\u7ec4\u7ec7\u4e2d\u6291\u5236\u6076\u6027B\u7ec6\u80de\u589e\u6b96\u3002<\/p>\n<p>\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5df2\u7ecf\u5f00\u5c55\u4e86\u5e7f\u6cdb\u7684\u5168\u7403\u4e34\u5e8a\u5f00\u53d1\u9879\u76ee\uff0c\u76ee\u524d\u5df2\u5728\u5168\u740328\u4e2a\u5e02\u573a\u4e2d\u5f00\u5c55\u4e8635\u9879\u8bd5\u9a8c\uff0c\u603b\u5165\u7ec4\u53d7\u8bd5\u8005\u8d85\u8fc73,900\u4eba\u3002\u8fc4\u4eca\u4e3a\u6b62\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5df2\u5728\u5305\u62ec\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u548c\u82f1\u56fd\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u5176\u4ed6\u56fd\u9645\u5e02\u573a\u768450\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u83b7\u5f9720\u591a\u9879\u6279\u51c6\u3002\u76ee\u524d\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5728\u5168\u7403\u8303\u56f4\u5185\u8fd8\u670940\u591a\u9879\u836f\u653f\u7533\u62a5\u6b63\u5728\u5ba1\u8bc4\u4e2d\u3002<\/p>\n<p><b>\u5173\u4e8e\u767e\u6d4e\u795e\u5dde\u80bf\u7624\u5b66<\/b><\/p>\n<p>\u767e\u6d4e\u795e\u5dde\u901a\u8fc7\u81ea\u4e3b\u7814\u53d1\u6216\u4e0e\u5fd7\u540c\u9053\u5408\u7684\u5408\u4f5c\u4f19\u4f34\u643a\u624b\uff0c\u4e0d\u65ad\u63a8\u52a8\u540c\u7c7b\u6700\u4f73\u6216\u540c\u7c7b\u7b2c\u4e00\u7684\u4e34\u5e8a\u5019\u9009\u836f\u7269\u7814\u53d1\uff0c\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u6709\u6548\u3001\u53ef\u53ca\u4e14\u53ef\u8d1f\u62c5\u7684\u836f\u7269\u3002\u516c\u53f8\u5168\u7403\u4e34\u5e8a\u7814\u7a76\u548c\u5f00\u53d1\u56e2\u961f\u5df2\u6709\u7ea62,900\u4eba\u4e14\u4ecd\u5728\u4e0d\u65ad\u58ee\u5927\uff0c\u76ee\u524d\u6b63\u5728\u5168\u7403\u8303\u56f4\u652f\u6301100\u591a\u9879\u6b63\u5728\u8fdb\u884c\u6216\u7b79\u5907\u4e2d\u7684\u4e34\u5e8a\u7814\u7a76\u7684\u5c55\u5f00\uff0c\u5df2\u62db\u52df\u60a3\u8005\u548c\u5065\u5eb7\u53d7\u8bd5\u8005\u8d85\u8fc716,000\u4eba\u3002\u516c\u53f8\u4ea7\u54c1\u7ba1\u7ebf\u6df1\u539a\u3001\u8bd5\u9a8c\u5e03\u5c40\u5e7f\u6cdb\uff0c\u8bd5\u9a8c\u5df2\u8986\u76d6\u5168\u7403\u8d85\u8fc745\u4e2a\u56fd\u5bb6\/\u5730\u533a\uff0c\u4e14\u5747\u7531\u516c\u53f8\u5185\u90e8\u56e2\u961f\u7275\u5934\u3002\u516c\u53f8\u6df1\u8015\u4e8e\u8840\u6db2\u80bf\u7624\u548c\u5b9e\u4f53\u80bf\u7624\u7684\u9776\u5411\u6cbb\u7597\u53ca\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u5f00\u53d1\uff0c\u540c\u65f6\u4e13\u6ce8\u4e8e\u5355\u836f\u7597\u6cd5\u548c\u8054\u5408\u7597\u6cd5\u7684\u63a2\u7d22\u3002\u76ee\u524d\uff0c\u767e\u6d4e\u795e\u5dde\u81ea\u4e3b\u7814\u53d1\u7684\u4e09\u6b3e\u836f\u7269\u5df2\u83b7\u6279\u4e0a\u5e02\uff1a\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\uff08BTK\u6291\u5236\u5242\uff0c\u5df2\u5728\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u53ca\u5176\u4ed6\u56fd\u9645\u5e02\u573a\u83b7\u6279\u4e0a\u5e02\uff09\u3001\u767e\u6cfd\u5b89<sup>&reg;<\/sup>\uff08\u53ef\u6709\u6548\u907f\u514dFc-\u03b3\u53d7\u4f53\u7ed3\u5408\u7684\u6297PD-1\u6297\u4f53\uff0c\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff09\u53ca\u767e\u6c47\u6cfd<sup>&reg;<\/sup>\uff08PARP\u6291\u5236\u5242\uff0c\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff09\u3002<\/p>\n<p>\u540c\u65f6\uff0c\u767e\u6d4e\u795e\u5dde\u8fd8\u4e0e\u5176\u4ed6\u521b\u65b0\u516c\u53f8\u5408\u4f5c\uff0c\u5171\u540c\u643a\u624b\u63a8\u8fdb\u521b\u65b0\u7597\u6cd5\u7684\u7814\u53d1\uff0c\u4ee5\u6ee1\u8db3\u5168\u7403\u5065\u5eb7\u9700\u6c42\u3002\u5728\u4e2d\u56fd\uff0c\u767e\u6d4e\u795e\u5dde\u6b63\u5728\u9500\u552e\u591a\u6b3e\u7531\u5b89\u8fdb\u3001\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u3001EUSA Pharma\u3001\u767e\u5965\u6cf0\u6388\u6743\u7684\u80bf\u7624\u836f\u7269\u3002\u516c\u53f8\u4e5f\u901a\u8fc7\u4e0e\u5305\u62ecMirati Therapeutics\u3001Seagen\u4ee5\u53caZymeworks\u5728\u5185\u7684\u591a\u5bb6\u516c\u53f8\u5408\u4f5c\uff0c\u66f4\u5927\u7a0b\u5ea6\u6ee1\u8db3\u5f53\u524d\u5168\u7403\u8303\u56f4\u5c1a\u672a\u88ab\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u3002<\/p>\n<p>2021\u5e741\u6708\uff0c\u767e\u6d4e\u795e\u5dde\u548c\u8bfa\u534e\u5ba3\u5e03\u5408\u4f5c\uff0c\u6388\u4e88\u8bfa\u534e\u5728\u5317\u7f8e\u3001\u6b27\u6d32\u548c\u65e5\u672c\u5171\u540c\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316\u767e\u6d4e\u795e\u5dde\u7684\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89<sup>&reg;<\/sup>\u3002\u57fa\u4e8e\u8fd9\u4e00\u5353\u6709\u6210\u6548\u7684\u5408\u4f5c\uff0c\u5305\u62ecFDA\u6b63\u5728\u8bc4\u5ba1\u7684\u65b0\u836f\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\uff08BLA\uff09\uff0c\u767e\u6d4e\u795e\u5dde\u548c\u8bfa\u534e\u4e8e2021\u5e7412\u6708\u5ba3\u5e03\u4e86\u5173\u4e8e\u6b63\u57283\u671f\u5f00\u53d1\u7684\u767e\u6d4e\u795e\u5ddeTIGIT\u6291\u5236\u5242\u6b27\u53f8\u73c0\u5229\u5355\u6297\u7684\u9009\u62e9\u6743\u3001\u5408\u4f5c\u548c\u8bb8\u53ef\u534f\u8bae\u3002\u8bfa\u534e\u548c\u767e\u6d4e\u795e\u5dde\u8fd8\u7b7e\u8ba2\u4e86\u4e00\u9879\u6218\u7565\u5546\u4e1a\u534f\u8bae\uff0c\u901a\u8fc7\u8be5\u534f\u8bae\uff0c\u767e\u6d4e\u795e\u5dde\u5c06\u5728\u4e2d\u56fd\u5883\u5185\u6307\u5b9a\u533a\u57df\u63a8\u5e7f5\u6b3e\u5df2\u83b7\u6279\u7684\u8bfa\u534e\u6297\u80bf\u7624\u836f\u7269\u3002<\/p>\n<p><b>\u5173\u4e8e\u767e\u6d4e\u795e\u5dde<\/b><\/p>\n<p>\u767e\u6d4e\u795e\u5dde\u662f\u4e00\u5bb6\u7acb\u8db3\u4e8e\u79d1\u5b66\u7684\u5168\u7403\u6027\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u521b\u65b0\u3001\u53ef\u8d1f\u62c5\u7684\u836f\u7269\uff0c\u65e8\u5728\u4e3a\u5168\u7403\u60a3\u8005\u6539\u5584\u6cbb\u7597\u6548\u679c\u3001\u63d0\u9ad8\u836f\u7269\u53ef\u53ca\u6027\u3002\u76ee\u524d\u516c\u53f8\u5e7f\u6cdb\u7684\u836f\u7269\u7ec4\u5408\u5305\u62ec40\u591a\u6b3e\u4e34\u5e8a\u5019\u9009\u836f\u7269\u3002\u516c\u53f8\u901a\u8fc7\u52a0\u5f3a\u81ea\u4e3b\u7814\u53d1\u80fd\u529b\u548c\u5408\u4f5c\uff0c\u52a0\u901f\u63a8\u8fdb\u591a\u5143\u3001\u521b\u65b0\u7684\u836f\u7269\u7ba1\u7ebf\u5f00\u53d1\u3002\u6211\u4eec\u81f4\u529b\u4e8e\u57282030\u5e74\u524d\u4e3a\u5168\u740320\u591a\u4ebf\u4eba\u5168\u9762\u6539\u5584\u836f\u7269\u53ef\u53ca\u6027\u3002\u767e\u6d4e\u795e\u5dde\u5728\u5168\u7403\u4e94\u5927\u6d32\u6253\u9020\u4e86\u4e00\u652f\u8d85\u8fc78,000\u4eba\u7684\u56e2\u961f\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee<a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http:\/\/www.beigene.com&amp;esheet=52522451&amp;newsitemid=20211104006165&amp;lan=en-US&amp;anchor=www.beigene.com&amp;index=1&amp;md5=9bc4a07c757a0f1520a0df6dbead3c29\" target=\"_blank\" rel=\"nofollow noopener\">http:\/\/www.beigene.com.cn<\/a>\u3002<\/p>\n<p><b>\u5173\u4e8e<\/b><b>NewBridge Pharmaceuticals<\/b><\/p>\n<p>NewBridge Pharmaceuticals\u662f\u4e00\u5bb6\u533a\u57df\u6027\u7684\u4e13\u4e1a\u533b\u836f\u516c\u53f8\uff0c\u62e5\u6709\u5b8c\u5584\u7684\u533b\u836f\u670d\u52a1\u5e73\u53f0\u4e0e\u4e13\u4e1a\u80fd\u529b\uff0c\u81f4\u529b\u4e8e\u63d0\u4f9b\u836f\u54c1\u51c6\u5165\u7684\u7ebd\u5e26\uff0c\u901a\u8fc7\u4e0e\u5168\u7403\u6027\u5236\u836f\u548c\u751f\u7269\u79d1\u6280\u516c\u53f8\u5408\u4f5c\uff0c\u5411MENA\u5730\u533a\u5f15\u5165\u548c\u5546\u4e1a\u5316\u90a3\u4e9b\u5df2\u5728\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u6216\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\u83b7\u6279\u7684\u521b\u65b0\u7597\u6cd5\uff0c\u6ee1\u8db3\u8be5\u533a\u57df\u60a3\u8005\u672a\u7adf\u7684\u533b\u7597\u9700\u6c42\u3002<\/p>\n<p>\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee<a href=\"http:\/\/www.nbpharma.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.nbpharma.com<\/a>\u3002<\/p>\n<p><b>\u524d\u77bb\u6027\u58f0\u660e<\/b><br \/>\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6839\u636e\u300a1995\u5e74\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u300b\uff08Private Securities Litigation Reform Act of 1995\uff09\u4ee5\u53ca\u5176\u4ed6\u8054\u90a6\u8bc1\u5238\u6cd5\u4e2d\u5b9a\u4e49\u7684\u524d\u77bb\u6027\u58f0\u660e\uff0c\u5305\u62ec\u5173\u4e8e\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u7684\u4e34\u5e8a\u83b7\u76ca\u4e0e\u4e3a\u60a3\u8005\u6539\u5584\u6cbb\u7597\u7ed3\u5c40\u7684\u6f5c\u529b\uff0c\u767e\u60a6\u6cfd<sup>&reg;<\/sup>\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u3001\u5361\u5854\u5c14\u548c\u5176\u4ed6\u5e02\u573a\u7684\u5546\u4e1a\u5316\u548c\u5e02\u573a\u51c6\u5165\u8ba1\u5212\u7684\u58f0\u660e\uff0c\u4ee5\u53ca\u5728&quot;\u5173\u4e8e\u767e\u6d4e\u795e\u5dde\u80bf\u7624\u5b66&quot;\u548c&quot;\u5173\u4e8e\u767e\u6d4e\u795e\u5dde&quot;\u526f\u6807\u9898\u4e0b\u63d0\u53ca\u7684\u767e\u6d4e\u795e\u5dde\u8ba1\u5212\u3001\u627f\u8bfa\u3001\u62b1\u8d1f\u548c\u76ee\u6807\u3002\u7531\u4e8e\u5404\u79cd\u91cd\u8981\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4e0e\u524d\u77bb\u6027\u58f0\u660e\u6709\u91cd\u5927\u5dee\u5f02\u3002\u8fd9\u4e9b\u56e0\u7d20\u5305\u62ec\u4e86\u4ee5\u4e0b\u4e8b\u9879\u7684\u98ce\u9669\uff1a\u767e\u6d4e\u795e\u5dde\u8bc1\u660e\u5176\u5019\u9009\u836f\u7269\u529f\u6548\u548c\u5b89\u5168\u6027\u7684\u80fd\u529b\uff1b\u5019\u9009\u836f\u7269\u7684\u4e34\u5e8a\u7ed3\u679c\u53ef\u80fd\u4e0d\u652f\u6301\u8fdb\u4e00\u6b65\u5f00\u53d1\u6216\u4e0a\u5e02\u5ba1\u6279\uff1b\u836f\u653f\u90e8\u95e8\u7684\u884c\u52a8\u53ef\u80fd\u4f1a\u5f71\u54cd\u5230\u4e34\u5e8a\u8bd5\u9a8c\u7684\u542f\u52a8\u3001\u65f6\u95f4\u8868\u548c\u8fdb\u5c55\u4ee5\u53ca\u836f\u7269\u4e0a\u5e02\u5ba1\u6279\uff1b\u767e\u6d4e\u795e\u5dde\u7684\u4e0a\u5e02\u836f\u7269\u53ca\u5019\u9009\u836f\u7269\uff08\u5982\u80fd\u83b7\u6279\uff09\u83b7\u5f97\u5546\u4e1a\u6210\u529f\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u83b7\u5f97\u548c\u7ef4\u62a4\u5bf9\u5176\u836f\u7269\u548c\u6280\u672f\u7684\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u4f9d\u8d56\u7b2c\u4e09\u65b9\u8fdb\u884c\u836f\u7269\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5176\u4ed6\u670d\u52a1\u7684\u60c5\u51b5\uff1b\u767e\u6d4e\u795e\u5dde\u53d6\u5f97\u76d1\u7ba1\u5ba1\u6279\u548c\u5546\u4e1a\u5316\u533b\u836f\u4ea7\u54c1\u7684\u6709\u9650\u7ecf\u9a8c\uff0c\u53ca\u5176\u83b7\u5f97\u8fdb\u4e00\u6b65\u7684\u8425\u8fd0\u8d44\u91d1\u4ee5\u5b8c\u6210\u5019\u9009\u836f\u7269\u5f00\u53d1\u548c\u5b9e\u73b0\u5e76\u4fdd\u6301\u76c8\u5229\u7684\u80fd\u529b\uff1b\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c\u5bf9\u767e\u6d4e\u795e\u5dde\u7684\u4e34\u5e8a\u5f00\u53d1\u3001\u76d1\u7ba1\u3001\u5546\u4e1a\u5316\u8fd0\u8425\u3001\u751f\u4ea7\u4ee5\u53ca\u5176\u4ed6\u4e1a\u52a1\u5e26\u6765\u7684\u5f71\u54cd\uff1b\u767e\u6d4e\u795e\u5dde\u5728\u6700\u8fd1\u5b63\u5ea6\u62a5\u544a\u768410-Q\u8868\u683c\u4e2d&quot;\u98ce\u9669\u56e0\u7d20&quot;\u7ae0\u8282\u91cc\u66f4\u5168\u9762\u8ba8\u8bba\u7684\u5404\u7c7b\u98ce\u9669\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u671f\u540e\u5448\u62a5\u4e2d\u5173\u4e8e\u6f5c\u5728\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u7684\u8ba8\u8bba\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u7684\u6240\u6709\u4fe1\u606f\u4ec5\u53ca\u4e8e\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\uff0c\u9664\u975e\u6cd5\u5f8b\u8981\u6c42\uff0c\u767e\u6d4e\u795e\u5dde\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u8be5\u7b49\u4fe1\u606f\u3002<\/p>\n<p><b>\u53c2\u8003\u6587\u732e\uff1a<\/b><\/p>\n<p>i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Global Cancer Observatory &#8211; All Rights Reserved &#8211; March, 2021.<\/p>\n<p>ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span class=\"xn-person\">Philip J. Bierman<\/span>, <span class=\"xn-person\">James O. Armitage<\/span>, in Goldman&#8217;s <span class=\"xn-person\">Cecil Medicine<\/span> (Twenty Fourth Edition), 2012.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7ee7\u767e\u60a6\u6cfd&reg;\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u83b7\u6279\u7528\u4e8e\u6cbb\u7597\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\u540e\uff0c\u767e\u6d4e\u795e\u5dde\u6b63\u4e0eNewBridge Pharmaceuticals\u643a\u624b\u63a8\u52a8\u767e\u60a6\u6cfd&reg;\u60e0\u53ca\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08MENA\uff09\u7684\u60a3\u8005 \u6b64\u524d\uff0c\u767e\u60a6\u6cfd&reg;\u5df2\u5728\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u3001\u82f1\u56fd\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u3001\u97e9\u56fd\u548c\u745e\u58eb\u7b49\u5e02\u573a\u83b7\u5f97\u6279\u51c6 \u4e2d\u56fd\u5317\u4eac\u3001\u7f8e\u56fd\u9ebb\u7701\u5251\u6865\u548c\u745e\u58eb\u5df4\u585e\u5c142022\u5e746\u670813\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u767e\u6d4e\u795e\u5dde\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aBGNE\uff1b\u9999\u6e2f\u8054\u4ea4\u6240\u4ee3\u7801\uff1a06160\uff1b\u4e0a\u4ea4\u6240\u4ee3\u7801\uff1a688235\uff09\u662f\u4e00\u5bb6\u7acb\u8db3\u4e8e\u79d1\u5b66\u7684\u5168\u7403\u6027\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u521b\u65b0\u3001\u53ef\u8d1f\u62c5\u7684\u836f\u7269\uff0c\u65e8\u5728\u4e3a\u5168\u7403\u60a3\u8005\u6539\u5584\u6cbb\u7597\u6548\u679c\uff0c\u63d0\u9ad8\u836f\u7269\u53ef\u53ca\u6027\u3002\u516c\u53f8\u4e8e\u4eca\u65e5\u5ba3\u5e03\uff0c\u79d1\u5a01\u7279\u536b\u751f\u90e8\u3001\u5df4\u6797\u56fd\u5bb6\u536b\u751f\u76d1\u7763\u7ba1\u7406\u5c40\u548c\u5361\u5854\u5c14\u516c\u5171\u536b\u751f\u90e8\u5df2\u6279\u51c6\u767e\u6d4e\u795e\u5dde\u7684BTK\u6291\u5236\u5242\u767e\u60a6\u6cfd&reg;\uff08\u6cfd\u5e03\u66ff\u5c3c\uff09\u7528\u4e8e\u6cbb\u7597\u65e2\u5f80\u63a5\u53d7\u8fc7\u81f3\u5c11\u4e00\u79cd\u6cbb\u7597\u7684\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MCL\uff09\u6210\u4eba\u60a3\u8005\u3002\u767e\u6d4e\u795e\u5dde\u6b63\u5728\u4e0eNewBridge Pharmaceuticals\u5408\u4f5c\uff0c\u8be5\u516c\u53f8\u662f\u4e00\u5bb6\u4f4d\u4e8e\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08MENA\uff09\u7684\u4e13\u4e1a\u533b\u836f\u516c\u53f8\uff0c\u901a\u8fc7\u4e0e\u5168\u7403\u6027\u5236\u836f\u548c\u751f\u7269\u79d1\u6280\u516c\u53f8\u5408\u4f5c\uff0c\u81f4\u529b\u4e8e\u63d0\u4f9b\u836f\u54c1\u51c6\u5165\u7684\u7ebd\u5e26\u3002\u5728\u83b7\u5f97\u5f53\u5730\u76d1\u7ba1\u673a\u6784\u6279\u51c6\u540e\uff0c\u53cc\u65b9\u5c06\u628a\u767e\u60a6\u6cfd&reg;\u5e26\u7ed9\u79d1\u5a01\u7279\u3001\u5df4\u6797\u3001\u5361\u5854\u5c14\u3001\u6c99\u7279\u963f\u62c9\u4f2f\u3001\u963f\u62c9\u4f2f\u8054\u5408\u914b\u957f\u56fd\u53ca\u5176\u4ed6\u4e2d\u4e1c\u548c\u5317\u975e\u5730\u533a\uff08MENA\uff09\u5e02\u573a\u7684\u60a3\u8005\u3002 \u79d1\u5a01\u7279\u764c\u75c7\u63a7\u5236\u4e2d\u5fc3\u8840\u6db2\u79d1\u8d1f\u8d23\u4ebaAbdul Aziz Hamadah\u535a\u58eb\u8868\u793a\uff1a&quot;\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u662f\u6700\u5e38\u89c1\u7684\u4e94\u5927\u764c\u75c7\u7c7b\u578b\u4e4b\u4e00\uff0c\u5176\u4e2dMCL\u60a3\u8005\u7684\u9884\u540e\u5c24\u5176\u4e0d\u7406\u60f3\u3002\u8fd9\u7c7b\u60a3\u8005\u901a\u5e38\u9700\u8981\u591a\u7ebf\u6cbb\u7597\uff0c\u800c\u4e14\u540e\u7eed\u6cbb\u7597\u7684\u7f13\u89e3\u6301\u7eed\u65f6\u95f4\u4f1a\u4e0d\u65ad\u7f29\u77ed\u3002\u6b64\u6b21\u83b7\u6279\u7684\u65b0\u4e00\u4ee3BTK\u6291\u5236\u5242\u767e\u60a6\u6cfd&reg;\u662f\u4e00\u79cd\u5f3a\u6548\u3001\u9ad8\u9009\u62e9\u6027\u548c\u9ad8\u751f\u7269\u5229\u7528\u5ea6\u7684\u4e0d\u53ef\u9006\u6027BTK\u6291\u5236\u5242\uff0c\u5177\u6709\u6f5c\u5728\u66f4\u4f18\u7684\u836f\u4ee3\u52a8\u529b\u5b66\u548c\u836f\u6548\u5b66\u7279\u6027\u3002&quot; \u767e\u6d4e\u795e\u5ddeMENA\u65b0\u5174\u5e02\u573a\u9ad8\u7ea7\u603b\u76d1Mohammed Al-Kapany\u8868\u793a\uff1a&quot;\u767e\u6d4e\u795e\u5dde\u7684\u613f\u666f\u662f\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u66f4\u591a\u60a3\u8005\u63d0\u4f9b\u6709\u6548\u3001\u53ef\u53ca\u4e14\u53ef\u8d1f\u62c5\u7684\u521b\u65b0\u836f\u7269\u3002\u5728\u8fc7\u53bb\u7684\u4e00\u5e74\u4e2d\uff0c\u767e\u60a6\u6cfd&reg;\u5df2\u5728MENA\u5730\u533a\u7684\u4e94\u4e2a\u56fd\u5bb6\u83b7\u6279\uff0c\u5305\u62ec\u6c99\u7279\u963f\u62c9\u4f2f\u3001\u963f\u62c9\u4f2f\u8054\u5408\u914b\u957f\u56fd\u3001\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u3002\u6b64\u6b21\u80fd\u591f\u4e3a\u66f4\u591a\u60a3\u8005\u5e26\u6765\u8fd9\u4e00\u91cd\u8981\u7684\u65b0\u6cbb\u7597\u9009\u62e9\uff0c\u6211\u4eec\u500d\u611f\u81ea\u8c6a\u3002&quot; NewBridge Pharmaceuticals\u603b\u88c1\u517c\u9996\u5e2d\u6267\u884c\u5b98Joe Henein\u8865\u5145\u9053\uff1a&quot;\u6211\u4eec\u5c06\u7ee7\u7eed\u4e0e\u767e\u6d4e\u795e\u5dde\u5728MENA\u5730\u533a\u8fdb\u884c\u5bcc\u6709\u6210\u6548\u7684\u5408\u4f5c\uff0c\u4e5f\u671f\u5f85\u5c06\u767e\u60a6\u6cfd&reg;\u5e26\u7ed9\u79d1\u5a01\u7279\u3001\u5df4\u6797\u548c\u5361\u5854\u5c14\u7684\u533b\u751f\u53ca\u5176\u60a3\u8005\u3002&quot; \u767e\u60a6\u6cfd&reg;\u7684\u63a8\u8350\u5242\u91cf\u4e3a160 mg\u6bcf\u65e5\u4e24\u6b21\uff0c\u6216320 mg\u6bcf\u65e5\u4e00\u6b21\uff0c\u7a7a\u8179\u6216\u9910\u540e\u53e3\u670d\u5747\u53ef\u3002\u53ef\u6839\u636e\u4e0d\u826f\u53cd\u5e94\u8c03\u6574\u5242\u91cf\uff0c\u5bf9\u4e8e\u5b58\u5728\u91cd\u5ea6\u809d\u635f\u5bb3\uff0c\u6216\u6b63\u5728\u670d\u7528\u4e0e\u767e\u60a6\u6cfd&reg;\u5b58\u5728\u6f5c\u5728\u836f\u7269\u76f8\u4e92\u4f5c\u7528\u7684\u836f\u7269\u7684\u60a3\u8005\uff0c\u53ef\u964d\u4f4e\u5242\u91cf\u3002 \u5173\u4e8e\u5957\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MCL\uff09&nbsp; \u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08NHL\uff09\u662f\u79d1\u5a01\u7279\u7b2c\u4e94\u5927\u5e38\u89c1\u7684\u764c\u75c7\u79cd\u7c7b\u4e4b\u4e00\u3002i MCL\u662f\u4e00\u79cd\u7f55\u89c1\u7684NHL\uff0c\u5360\u6240\u6709NHL\u75c5\u4f8b\u76845%\u3002MCL\u4e3b\u8981\u51fa\u73b0\u5728\u88ab\u79f0\u4e3a\u5957\u533a\u7684\u6dcb\u5df4\u7ed3\u5916\u7f18\u3002\u76f8\u8f83\u5973\u6027\uff0cMCL\u66f4\u591a\u53d1\u4e8e\u7537\u6027\u60a3\u8005\uff0c\u60a3\u8005\u901a\u5e38\u572860\u5c81\u5de6\u53f3\u786e\u8bca\u3002MCL\u60a3\u8005\u9884\u540e\u901a\u5e38\u8f83\u4e0d\u7406\u60f3\uff0c\u4e2d\u4f4d\u751f\u5b58\u671f\u4ec5\u4e3a3&nbsp;~&nbsp;4\u5e74\uff0c\u8bb8\u591a\u60a3\u8005\u5728\u786e\u8bca\u65f6\u5e38\u5e38\u5df2\u7ecf\u5904\u4e8e\u75be\u75c5\u665a\u671f\u3002ii&nbsp; \u5173\u4e8e\u767e\u60a6\u6cfd&reg; \u767e\u60a6\u6cfd&reg;\uff08\u6cfd\u5e03\u66ff\u5c3c\uff09\u662f\u4e00\u6b3e\u7531\u767e\u6d4e\u795e\u5dde\u79d1\u5b66\u5bb6\u81ea\u4e3b\u7814\u53d1\u7684\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u5c0f\u5206\u5b50\u6291\u5236\u5242\uff0c\u76ee\u524d\u6b63\u5728\u5168\u7403\u8fdb\u884c\u5e7f\u6cdb\u7684\u4e34\u5e8a\u8bd5\u9a8c\u9879\u76ee\uff0c\u4f5c\u4e3a\u5355\u836f\u548c\u4e0e\u5176\u4ed6\u7597\u6cd5\u8fdb\u884c\u8054\u5408\u7528\u836f\u6cbb\u7597\u591a\u79cdB\u7ec6\u80de\u6076\u6027\u80bf\u7624\u3002\u7531\u4e8e\u65b0\u7684BTK\u4f1a\u5728\u4eba\u4f53\u5185\u4e0d\u65ad\u5408\u6210\uff0c\u767e\u60a6\u6cfd&reg;\u7684\u8bbe\u8ba1\u901a\u8fc7\u4f18\u5316\u751f\u7269\u5229\u7528\u5ea6\u3001\u534a\u8870\u671f\u548c\u9009\u62e9\u6027\uff0c\u5b9e\u73b0\u5bf9BTK\u86cb\u767d\u5b8c\u5168\u3001\u6301\u7eed\u7684\u6291\u5236\u3002\u51ed\u501f\u4e0e\u5176\u4ed6\u83b7\u6279BTK\u6291\u5236\u5242\u5b58\u5728\u5dee\u5f02\u5316\u7684\u836f\u4ee3\u52a8\u529b\u5b66\uff0c\u767e\u60a6\u6cfd&reg;\u80fd\u5728\u591a\u4e2a\u75be\u75c5\u76f8\u5173\u7ec4\u7ec7\u4e2d\u6291\u5236\u6076\u6027B\u7ec6\u80de\u589e\u6b96\u3002 \u767e\u60a6\u6cfd&reg;\u5df2\u7ecf\u5f00\u5c55\u4e86\u5e7f\u6cdb\u7684\u5168\u7403\u4e34\u5e8a\u5f00\u53d1\u9879\u76ee\uff0c\u76ee\u524d\u5df2\u5728\u5168\u740328\u4e2a\u5e02\u573a\u4e2d\u5f00\u5c55\u4e8635\u9879\u8bd5\u9a8c\uff0c\u603b\u5165\u7ec4\u53d7\u8bd5\u8005\u8d85\u8fc73,900\u4eba\u3002\u8fc4\u4eca\u4e3a\u6b62\uff0c\u767e\u60a6\u6cfd&reg;\u5df2\u5728\u5305\u62ec\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u548c\u82f1\u56fd\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u548c\u5176\u4ed6\u56fd\u9645\u5e02\u573a\u768450\u4e2a\u56fd\u5bb6\u548c\u5730\u533a\u83b7\u5f9720\u591a\u9879\u6279\u51c6\u3002\u76ee\u524d\uff0c\u767e\u60a6\u6cfd&reg;\u5728\u5168\u7403\u8303\u56f4\u5185\u8fd8\u670940\u591a\u9879\u836f\u653f\u7533\u62a5\u6b63\u5728\u5ba1\u8bc4\u4e2d\u3002 \u5173\u4e8e\u767e\u6d4e\u795e\u5dde\u80bf\u7624\u5b66 \u767e\u6d4e\u795e\u5dde\u901a\u8fc7\u81ea\u4e3b\u7814\u53d1\u6216\u4e0e\u5fd7\u540c\u9053\u5408\u7684\u5408\u4f5c\u4f19\u4f34\u643a\u624b\uff0c\u4e0d\u65ad\u63a8\u52a8\u540c\u7c7b\u6700\u4f73\u6216\u540c\u7c7b\u7b2c\u4e00\u7684\u4e34\u5e8a\u5019\u9009\u836f\u7269\u7814\u53d1\uff0c\u81f4\u529b\u4e8e\u4e3a\u5168\u7403\u60a3\u8005\u63d0\u4f9b\u6709\u6548\u3001\u53ef\u53ca\u4e14\u53ef\u8d1f\u62c5\u7684\u836f\u7269\u3002\u516c\u53f8\u5168\u7403\u4e34\u5e8a\u7814\u7a76\u548c\u5f00\u53d1\u56e2\u961f\u5df2\u6709\u7ea62,900\u4eba\u4e14\u4ecd\u5728\u4e0d\u65ad\u58ee\u5927\uff0c\u76ee\u524d\u6b63\u5728\u5168\u7403\u8303\u56f4\u652f\u6301100\u591a\u9879\u6b63\u5728\u8fdb\u884c\u6216\u7b79\u5907\u4e2d\u7684\u4e34\u5e8a\u7814\u7a76\u7684\u5c55\u5f00\uff0c\u5df2\u62db\u52df\u60a3\u8005\u548c\u5065\u5eb7\u53d7\u8bd5\u8005\u8d85\u8fc716,000\u4eba\u3002\u516c\u53f8\u4ea7\u54c1\u7ba1\u7ebf\u6df1\u539a\u3001\u8bd5\u9a8c\u5e03\u5c40\u5e7f\u6cdb\uff0c\u8bd5\u9a8c\u5df2\u8986\u76d6\u5168\u7403\u8d85\u8fc745\u4e2a\u56fd\u5bb6\/\u5730\u533a\uff0c\u4e14\u5747\u7531\u516c\u53f8\u5185\u90e8\u56e2\u961f\u7275\u5934\u3002\u516c\u53f8\u6df1\u8015\u4e8e\u8840\u6db2\u80bf\u7624\u548c\u5b9e\u4f53\u80bf\u7624\u7684\u9776\u5411\u6cbb\u7597\u53ca\u80bf\u7624\u514d\u75ab\u6cbb\u7597\u7684\u5f00\u53d1\uff0c\u540c\u65f6\u4e13\u6ce8\u4e8e\u5355\u836f\u7597\u6cd5\u548c\u8054\u5408\u7597\u6cd5\u7684\u63a2\u7d22\u3002\u76ee\u524d\uff0c\u767e\u6d4e\u795e\u5dde\u81ea\u4e3b\u7814\u53d1\u7684\u4e09\u6b3e\u836f\u7269\u5df2\u83b7\u6279\u4e0a\u5e02\uff1a\u767e\u60a6\u6cfd&reg;\uff08BTK\u6291\u5236\u5242\uff0c\u5df2\u5728\u7f8e\u56fd\u3001\u4e2d\u56fd\u3001\u6b27\u76df\u3001\u52a0\u62ff\u5927\u3001\u6fb3\u5927\u5229\u4e9a\u53ca\u5176\u4ed6\u56fd\u9645\u5e02\u573a\u83b7\u6279\u4e0a\u5e02\uff09\u3001\u767e\u6cfd\u5b89&reg;\uff08\u53ef\u6709\u6548\u907f\u514dFc-\u03b3\u53d7\u4f53\u7ed3\u5408\u7684\u6297PD-1\u6297\u4f53\uff0c\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff09\u53ca\u767e\u6c47\u6cfd&reg;\uff08PARP\u6291\u5236\u5242\uff0c\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\uff09\u3002 \u540c\u65f6\uff0c\u767e\u6d4e\u795e\u5dde\u8fd8\u4e0e\u5176\u4ed6\u521b\u65b0\u516c\u53f8\u5408\u4f5c\uff0c\u5171\u540c\u643a\u624b\u63a8\u8fdb\u521b\u65b0\u7597\u6cd5\u7684\u7814\u53d1\uff0c\u4ee5\u6ee1\u8db3\u5168\u7403\u5065\u5eb7\u9700\u6c42\u3002\u5728\u4e2d\u56fd\uff0c\u767e\u6d4e\u795e\u5dde\u6b63\u5728\u9500\u552e\u591a\u6b3e\u7531\u5b89\u8fdb\u3001\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u3001EUSA Pharma\u3001\u767e\u5965\u6cf0\u6388\u6743\u7684\u80bf\u7624\u836f\u7269\u3002\u516c\u53f8\u4e5f\u901a\u8fc7\u4e0e\u5305\u62ecMirati Therapeutics\u3001Seagen\u4ee5\u53caZymeworks\u5728\u5185\u7684\u591a\u5bb6\u516c\u53f8\u5408\u4f5c\uff0c\u66f4\u5927\u7a0b\u5ea6\u6ee1\u8db3\u5f53\u524d\u5168\u7403\u8303\u56f4\u5c1a\u672a\u88ab\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u3002 2021\u5e741\u6708\uff0c\u767e\u6d4e\u795e\u5dde\u548c\u8bfa\u534e\u5ba3\u5e03\u5408\u4f5c\uff0c\u6388\u4e88\u8bfa\u534e\u5728\u5317\u7f8e\u3001\u6b27\u6d32\u548c\u65e5\u672c\u5171\u540c\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5546\u4e1a\u5316\u767e\u6d4e\u795e\u5dde\u7684\u6297PD-1\u6297\u4f53\u767e\u6cfd\u5b89&reg;\u3002\u57fa\u4e8e\u8fd9\u4e00\u5353\u6709\u6210\u6548\u7684\u5408\u4f5c\uff0c\u5305\u62ecFDA\u6b63\u5728\u8bc4\u5ba1\u7684\u65b0\u836f\u4e0a\u5e02\u8bb8\u53ef\u7533\u8bf7\uff08BLA\uff09\uff0c\u767e\u6d4e\u795e\u5dde\u548c\u8bfa\u534e\u4e8e2021\u5e7412\u6708\u5ba3\u5e03\u4e86\u5173\u4e8e\u6b63\u57283\u671f\u5f00\u53d1\u7684\u767e\u6d4e\u795e\u5ddeTIGIT\u6291\u5236\u5242\u6b27\u53f8\u73c0\u5229\u5355\u6297\u7684\u9009\u62e9\u6743\u3001\u5408\u4f5c\u548c\u8bb8\u53ef\u534f\u8bae\u3002\u8bfa\u534e\u548c\u767e\u6d4e\u795e\u5dde\u8fd8\u7b7e\u8ba2\u4e86\u4e00\u9879\u6218\u7565\u5546\u4e1a\u534f\u8bae\uff0c\u901a\u8fc7\u8be5\u534f\u8bae\uff0c\u767e\u6d4e\u795e\u5dde\u5c06\u5728\u4e2d\u56fd\u5883\u5185\u6307\u5b9a\u533a\u57df\u63a8\u5e7f5\u6b3e\u5df2\u83b7\u6279\u7684\u8bfa\u534e\u6297\u80bf\u7624\u836f\u7269\u3002 \u5173\u4e8e\u767e\u6d4e\u795e\u5dde \u767e\u6d4e\u795e\u5dde\u662f\u4e00\u5bb6\u7acb\u8db3\u4e8e\u79d1\u5b66\u7684\u5168\u7403\u6027\u751f\u7269\u79d1\u6280\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u5f00\u53d1\u521b\u65b0\u3001\u53ef\u8d1f\u62c5\u7684\u836f\u7269\uff0c\u65e8\u5728\u4e3a\u5168\u7403\u60a3\u8005\u6539\u5584\u6cbb\u7597\u6548\u679c\u3001\u63d0\u9ad8\u836f\u7269\u53ef\u53ca\u6027\u3002\u76ee\u524d\u516c\u53f8\u5e7f\u6cdb\u7684\u836f\u7269\u7ec4\u5408\u5305\u62ec40\u591a\u6b3e\u4e34\u5e8a\u5019\u9009\u836f\u7269\u3002\u516c\u53f8\u901a\u8fc7\u52a0\u5f3a\u81ea\u4e3b\u7814\u53d1\u80fd\u529b\u548c\u5408\u4f5c\uff0c\u52a0\u901f\u63a8\u8fdb\u591a\u5143\u3001\u521b\u65b0\u7684\u836f\u7269\u7ba1\u7ebf\u5f00\u53d1\u3002\u6211\u4eec\u81f4\u529b\u4e8e\u57282030\u5e74\u524d\u4e3a\u5168\u740320\u591a\u4ebf\u4eba\u5168\u9762\u6539\u5584\u836f\u7269\u53ef\u53ca\u6027\u3002\u767e\u6d4e\u795e\u5dde\u5728\u5168\u7403\u4e94\u5927\u6d32\u6253\u9020\u4e86\u4e00\u652f\u8d85\u8fc78,000\u4eba\u7684\u56e2\u961f\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eehttp:\/\/www.beigene.com.cn\u3002 \u5173\u4e8eNewBridge Pharmaceuticals NewBridge Pharmaceuticals\u662f\u4e00\u5bb6\u533a\u57df\u6027\u7684\u4e13\u4e1a\u533b\u836f\u516c\u53f8\uff0c\u62e5\u6709\u5b8c\u5584\u7684\u533b\u836f\u670d\u52a1\u5e73\u53f0\u4e0e\u4e13\u4e1a\u80fd\u529b\uff0c\u81f4\u529b\u4e8e\u63d0\u4f9b\u836f\u54c1\u51c6\u5165\u7684\u7ebd\u5e26\uff0c\u901a\u8fc7\u4e0e\u5168\u7403\u6027\u5236\u836f\u548c\u751f\u7269\u79d1\u6280\u516c\u53f8\u5408\u4f5c\uff0c\u5411MENA\u5730\u533a\u5f15\u5165\u548c\u5546\u4e1a\u5316\u90a3\u4e9b\u5df2\u5728\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\u6216\u6b27\u6d32\u836f\u54c1\u7ba1\u7406\u5c40\u83b7\u6279\u7684\u521b\u65b0\u7597\u6cd5\uff0c\u6ee1\u8db3\u8be5\u533a\u57df\u60a3\u8005\u672a\u7adf\u7684\u533b\u7597\u9700\u6c42\u3002 \u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95eewww.nbpharma.com\u3002 \u524d\u77bb\u6027\u58f0\u660e\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6839\u636e\u300a1995\u5e74\u79c1\u4eba\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u300b\uff08Private Securities Litigation Reform Act of 1995\uff09\u4ee5\u53ca\u5176\u4ed6\u8054\u90a6\u8bc1\u5238\u6cd5\u4e2d\u5b9a\u4e49\u7684\u524d\u77bb\u6027\u58f0\u660e\uff0c\u5305\u62ec\u5173\u4e8e\u767e\u60a6\u6cfd&reg;\u7684\u4e34\u5e8a\u83b7\u76ca\u4e0e\u4e3a\u60a3\u8005\u6539\u5584\u6cbb\u7597\u7ed3\u5c40\u7684\u6f5c\u529b\uff0c\u767e\u60a6\u6cfd&reg;\u5728\u79d1\u5a01\u7279\u3001\u5df4\u6797\u3001\u5361\u5854\u5c14\u548c\u5176\u4ed6\u5e02\u573a\u7684\u5546\u4e1a\u5316\u548c\u5e02\u573a\u51c6\u5165\u8ba1\u5212\u7684\u58f0\u660e\uff0c\u4ee5\u53ca\u5728&quot;\u5173\u4e8e\u767e\u6d4e\u795e\u5dde\u80bf\u7624\u5b66&quot;\u548c&quot;\u5173\u4e8e\u767e\u6d4e\u795e\u5dde&quot;\u526f\u6807\u9898\u4e0b\u63d0\u53ca\u7684\u767e\u6d4e\u795e\u5dde\u8ba1\u5212\u3001\u627f\u8bfa\u3001\u62b1\u8d1f\u548c\u76ee\u6807\u3002\u7531\u4e8e\u5404\u79cd\u91cd\u8981\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4e0e\u524d\u77bb\u6027\u58f0\u660e\u6709\u91cd\u5927\u5dee\u5f02\u3002\u8fd9\u4e9b\u56e0\u7d20\u5305\u62ec\u4e86\u4ee5\u4e0b\u4e8b\u9879\u7684\u98ce\u9669\uff1a\u767e\u6d4e\u795e\u5dde\u8bc1\u660e\u5176\u5019\u9009\u836f\u7269\u529f\u6548\u548c\u5b89\u5168\u6027\u7684\u80fd\u529b\uff1b\u5019\u9009\u836f\u7269\u7684\u4e34\u5e8a\u7ed3\u679c\u53ef\u80fd\u4e0d\u652f\u6301\u8fdb\u4e00\u6b65\u5f00\u53d1\u6216\u4e0a\u5e02\u5ba1\u6279\uff1b\u836f\u653f\u90e8\u95e8\u7684\u884c\u52a8\u53ef\u80fd\u4f1a\u5f71\u54cd\u5230\u4e34\u5e8a\u8bd5\u9a8c\u7684\u542f\u52a8\u3001\u65f6\u95f4\u8868\u548c\u8fdb\u5c55\u4ee5\u53ca\u836f\u7269\u4e0a\u5e02\u5ba1\u6279\uff1b\u767e\u6d4e\u795e\u5dde\u7684\u4e0a\u5e02\u836f\u7269\u53ca\u5019\u9009\u836f\u7269\uff08\u5982\u80fd\u83b7\u6279\uff09\u83b7\u5f97\u5546\u4e1a\u6210\u529f\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u83b7\u5f97\u548c\u7ef4\u62a4\u5bf9\u5176\u836f\u7269\u548c\u6280\u672f\u7684\u77e5\u8bc6\u4ea7\u6743\u4fdd\u62a4\u7684\u80fd\u529b\uff1b\u767e\u6d4e\u795e\u5dde\u4f9d\u8d56\u7b2c\u4e09\u65b9\u8fdb\u884c\u836f\u7269\u5f00\u53d1\u3001\u751f\u4ea7\u548c\u5176\u4ed6\u670d\u52a1\u7684\u60c5\u51b5\uff1b\u767e\u6d4e\u795e\u5dde\u53d6\u5f97\u76d1\u7ba1\u5ba1\u6279\u548c\u5546\u4e1a\u5316\u533b\u836f\u4ea7\u54c1\u7684\u6709\u9650\u7ecf\u9a8c\uff0c\u53ca\u5176\u83b7\u5f97\u8fdb\u4e00\u6b65\u7684\u8425\u8fd0\u8d44\u91d1\u4ee5\u5b8c\u6210\u5019\u9009\u836f\u7269\u5f00\u53d1\u548c\u5b9e\u73b0\u5e76\u4fdd\u6301\u76c8\u5229\u7684\u80fd\u529b\uff1b\u65b0\u51a0\u80ba\u708e\u5168\u7403\u5927\u6d41\u884c\u5bf9\u767e\u6d4e\u795e\u5dde\u7684\u4e34\u5e8a\u5f00\u53d1\u3001\u76d1\u7ba1\u3001\u5546\u4e1a\u5316\u8fd0\u8425\u3001\u751f\u4ea7\u4ee5\u53ca\u5176\u4ed6\u4e1a\u52a1\u5e26\u6765\u7684\u5f71\u54cd\uff1b\u767e\u6d4e\u795e\u5dde\u5728\u6700\u8fd1\u5b63\u5ea6\u62a5\u544a\u768410-Q\u8868\u683c\u4e2d&quot;\u98ce\u9669\u56e0\u7d20&quot;\u7ae0\u8282\u91cc\u66f4\u5168\u9762\u8ba8\u8bba\u7684\u5404\u7c7b\u98ce\u9669\uff1b\u4ee5\u53ca\u767e\u6d4e\u795e\u5dde\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u671f\u540e\u5448\u62a5\u4e2d\u5173\u4e8e\u6f5c\u5728\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u4ee5\u53ca\u5176\u4ed6\u91cd\u8981\u56e0\u7d20\u7684\u8ba8\u8bba\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u7684\u6240\u6709\u4fe1\u606f\u4ec5\u53ca\u4e8e\u65b0\u95fb\u7a3f\u53d1\u5e03\u4e4b\u65e5\uff0c\u9664\u975e\u6cd5\u5f8b\u8981\u6c42\uff0c\u767e\u6d4e\u795e\u5dde\u5e76\u65e0\u8d23\u4efb\u66f4\u65b0\u8be5\u7b49\u4fe1\u606f\u3002 \u53c2\u8003\u6587\u732e\uff1a i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Global Cancer Observatory &#8211; All Rights Reserved&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2022061318300069411\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-69411","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/69411","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=69411"}],"version-history":[{"count":1,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/69411\/revisions"}],"predecessor-version":[{"id":69412,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/69411\/revisions\/69412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=69411"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=69411"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=69411"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}